Founded in Barcelona in 2017, BENoBON draws on over two decades of expertise built by its founders across the generic pharmaceutical industry — from early-stage formulation development through to commercial strategy and market access. This deep domain knowledge, paired with extensive experience in information technology consulting, has naturally evolved into a forward-looking practice in blockchain and decentralized technologies. We bring the same rigour and strategic precision to Web3 that built our reputation in pharma.
WHAT WE DO
Comprehensive expertise spanning the full generic pharmaceutical value chain. From formulation development and regulatory strategy on the science side, to commercial operations and market access on the business side — two decades navigating the industry's most demanding challenges.
Strategic technology consulting at the intersection of business and infrastructure. From systems architecture and ERP implementations to IT security, user support, and digital transformation — with particular depth in the exacting requirements of regulated industries.
Full-stack development across Web2 and Web3. From modern web applications, APIs, and cloud infrastructure to decentralized solutions — dApp development, tokenized systems, and DeFi protocols. End-to-end delivery from architecture through production deployment.
COLLABORATIONS
Spanish pharmaceutical company specializing in the development and commercialization of generic medicines, with a strong focus on oral solid dosage forms and R&D services.
One of Portugal's largest pharmaceutical groups, with integrated capabilities spanning R&D, manufacturing, and distribution of generic medicines across European markets.
A leading DeFi protocol for active concentrated liquidity management, optimizing yields on decentralized exchanges through automated market-making strategies.
Pioneering unit-dose pharmaceutical solutions that enhance medication safety and efficiency across hospital and clinical environments.
Spanish pharmaceutical company specializing in the development and commercialization of generic medicines, with a strong focus on oral solid dosage forms and R&D services.
One of Portugal's largest pharmaceutical groups, with integrated capabilities spanning R&D, manufacturing, and distribution of generic medicines across European markets.
A leading DeFi protocol for active concentrated liquidity management, optimizing yields on decentralized exchanges through automated market-making strategies.
Pioneering unit-dose pharmaceutical solutions that enhance medication safety and efficiency across hospital and clinical environments.